Cart
sales@molnova.com
Lateritin
CAS No. 65454-13-9
Lateritin( Bassiatin )
Catalog No. M27818 CAS No. 65454-13-9
Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 221 | In Stock |
|
| 5MG | 257 | In Stock |
|
| 10MG | 364 | In Stock |
|
| 25MG | 546 | In Stock |
|
| 50MG | 723 | In Stock |
|
| 100MG | 977 | In Stock |
|
| 200MG | 1283 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLateritin
-
NoteResearch use only, not for human use.
-
Brief DescriptionLateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
DescriptionLateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
In Vitro——
-
In Vivo——
-
SynonymsBassiatin
-
PathwayOthers
-
TargetOther Targets
-
RecptorElastase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65454-13-9
-
Formula Weight261.321
-
Molecular FormulaC15H19NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)C1OC(=O)C(Cc2ccccc2)N(C)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hildreth, J.E.K. N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochem. J. 207(2), 363-366 (1982).
molnova catalog
related products
-
Isogambogic acid
Isogambogic acid shows cytotoxic activiity against KB and drug-resistant KB-V1 cell lines.
-
Glucoerucin
Glucoerucin is a natural product.
-
ML382
ML382 is a potent and selective MrgX1 positive allosteric modulator(EC50 : 190 nM).ML382 enhances the ability of BAM8-22 to inhibit high-voltage-activated Ca2+ channels and attenuate spinal nociceptive transmission, both BAM8-22 and ML382 effectively attenuated evoked, persistent, and spontaneous pain without causing obvious side effects.?
